BURLINGTON, Mass. - Neuphoria Therapeutics Inc. (NASDAQ:NEUP), a biotechnology firm focused on neuropsychiatric treatments with a market capitalization of $7.27 million, is set to receive a $15 ...

This $15M payment marks the second milestone achieved in the collaboration with Merck. Under the agreement, Neuphoria is eligible to receive up to $450M in additional milestone payments for certain ...

Howard Hughes Medical Institute investigator Nathaniel Heintz and his colleagues Inés Ibañez-Tallon and Julie Miwa at The Rockefeller University and colleagues at The Mayo Foundation and Columbia ...

Nicotine, a major component of tobacco smoke, could exert either nonreceptor-mediated biological effects or, more importantly, act on the different subtypes of nicotinic brain receptors ...